DVI
HLF icon

Deccan Value Investors’s Herbalife HLF Stock Holding History

Deccan Value Investors’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,062,839
Closed -$93M – 8
2022
Q1 		$93M Sell
3,062,839
-547,011
-15% -$21.4M 4.74% 9
2021
Q4 		$148M Sell
3,609,850
-135,443
-4% -$5.64M 5.8% 9
2021
Q3 		$159M Buy
3,745,293
+780,218
+26% +$38.6M 6.28% 9
2021
Q2 		$156M Buy
2,965,075
+45,085
+2% +$2.24M 6.16% 9
2021
Q1 		$130M Sell
2,919,990
-766,995
-21% -$37.8M 5.73% 9
2020
Q4 		$177M Sell
3,686,985
-388,889
-10% -$18.8M 7.19% 9
2020
Q3 		$190M Sell
4,075,874
-3,230,426
-44% -$159M 8.65% 7
2020
Q2 		$329M Sell
7,306,300
-5,287,880
-42% -$205M 17.1% 1
2020
Q1 		$367M Buy
12,594,180
+2,164,738
+21% +$80.6M 31.82% 1
2019
Q4 		$497M Sell
10,429,442
-1,375,966
-12% -$59.6M 40.45% 1
2019
Q3 		$447M Buy
11,805,408
+2,067,375
+21% +$80.7M 38.87% 1
2019
Q2 		$416M Buy
9,738,033
+3,671,203
+61% +$174M 35.69% 1
2019
Q1 		$321M Sell
6,066,830
-178,800
-3% -$10.3M 24.36% 1
2018
Q4 		$368M Sell
6,245,630
-74,817
-1% -$4.13M 27.85% 1
2018
Q3 		$345M Sell
6,320,447
-1,276,953
-17% -$70.5M 25.55% 1
2018
Q2 		$408M Sell
7,597,400
-1,059,000
-12% -$55.7M 31% 1
2018
Q1 		$422M Sell
8,656,400
-6,385,132
-42% -$271M 35.8% 1
2017
Q4 		$509M Sell
15,041,532
-594,788
-4% -$20.8M 40.18% 1
2017
Q3 		$530M Buy
15,636,320
+526,320
+3% +$18M 36.6% 1
2017
Q2 		$539M Sell
15,110,000
-390,800
-3% -$13.2M 32.59% 1
2017
Q1 		$451M Buy
15,500,800
+205,376
+1% +$5.71M 30.39% 1
2016
Q4 		$368M Buy
15,295,424
+7,480,824
+96% +$204M 26.81% 1
2016
Q3 		$242M Buy
7,814,600
+3,545,144
+83% +$112M 22.49% 1
2016
Q2 		$125M Sell
4,269,456
-1,162,942
-21% -$34.8M 14.75% 5
2016
Q1 		$167M Buy
5,432,398
+3,098,492
+133% +$80M 14.63% 3
2015
Q4 		$62.6M Hold
2,333,906
– – 8.18% 6
2015
Q3 		$63.6M Hold
2,333,906
– – 9.5% 6
2015
Q2 		$64.3M Hold
2,333,906
– – 14.65% 5
2015
Q1 		$49.9M Buy
+2,333,906
New +$39.9M 12.44% 5

Other funds holding HLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deccan Value Investors's HLF Position: Q2 2022 in Review

Deccan Value Investors sold out of Herbalife (HLF) in Q2 2022, closing a stake of 3,062,839 shares — an estimated $93M sold.

Deccan Value Investors first reported a position in HLF in Q1 2015 and held it in 29 quarters. The position peaked at $539M in Q2 2017. 204 funds tracked by Wall St. Rank hold HLF as of Q2 2022.

  • Deccan Value Investors reported no remaining Herbalife position as of Q2 2022 after selling out during the quarter.
  • Deccan Value Investors sold 3,062,839 Herbalife shares in Q2 2022, an estimated $93M.
  • Deccan Value Investors first reported a position in Herbalife in Q1 2015 and held it in 29 quarters.
  • Deccan Value Investors's Herbalife position peaked at $539M in Q2 2017.
  • 204 funds tracked by Wall St. Rank held Herbalife as of Q2 2022.

Based on Deccan Value Investors's 13F filing for Q2 2022, filed 15 Aug 2022.